18.50Open18.50Pre Close0 Volume1 Open Interest60.00Strike Price0.00Turnover7715.71%IV1.70%PremiumDec 13, 2024Expiry Date17.19Intrinsic Value100Multiplier-1DDays to Expiry1.31Extrinsic Value100Contract SizeAmericanOptions Type0.9663Delta0.0068Gamma4.64Leverage Ratio-311.1192Theta0.0000Rho4.48Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet